GL1X · GenesisL1 explorer

Research workbench

Cryo-EM structure of prefusion SARS-cov-2 spike omicron B.1.1.529 variant

Analyse Cryo-EM structure of prefusion SARS-cov-2 spike omicron B.1.1.529 variant in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7THK
Type
protein
Length
2,925 residues
Chains
3
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike glycoprotein
UniProt
P0DTC2
Ligands
NAG
Pockets
20 · best druggability 0.85

Structure

electron microscopy · 3 distinct chains · 23% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike glycoproteinprotein86026% helix, 32% strandP0DTC2
BSpike glycoproteinprotein104322% helix, 33% strandP0DTC2
CSpike glycoproteinprotein102222% helix, 32% strandP0DTC2

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 38 copies · chains A, C, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19120.850.87105empty
23690.840.9240empty
311370.830.84117empty
47550.820.8689empty
52160.800.9443empty

Interfaces

3 interfaces between chains.

  • A–B · 6187 Ų buried · 55 hydrogen bonds · protein-protein
  • B–C · 5901 Ų buried · 45 hydrogen bonds · protein-protein
  • A–C · 4862 Ų buried · 36 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 38 glycan, 36 disulfide (N-glycosylation, disulfide).

Compared structures

  • 7THK · Cryo-EM structure of prefusion SARS-CoV-2 spike omicron B.1.1.529 variant · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.